Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 19.72 | N/A |
| PEG Ratio (TTM) | -3.38 | N/A |
| P/S Ratio (TTM) | 0.54 | N/A |
| P/B Ratio (TTM) | 1.03 | N/A |
| P/FCF Ratio (TTM) | 8.32 | N/A |
| Price to 5YR AVG Earnings Ratio | 20.83 | N/A |
| Price to 5YR AVG FCF Ratio | 22.82 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.15% | N/A |
| ROE (TTM) | 5.75% | N/A |
| Net Profit Margin (TTM) | 2.72% | N/A |
| ROIC 5YR AVG | 12.14% | N/A |
Growth (90%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 39.96% | 124.07% | 72.28% |
| Revenue | 4.39% | 6.76% | 5.45% |
| Net Income | 44.84% | 155.24% | 91.37% |
| Cash Flow | 1,199.72% | 298.32% | 206.54% |
Health (35%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.82 | N/A |
| Quick Ratio (TTM) | 1.10 | N/A |
| D/E Ratio (TTM) | 0.59 | N/A |
| Interest Coverage (TTM) | 7.73 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 1.72 | N/A |
| LTL to 5YR AVG FCF | 10.33 | N/A |
| Shares Outstanding Growth 5YR AVG | 3.86% | N/A |